NSN - 6505-01-111-3195, 6505011113195 of Amoxapine Tablets U

Aviation Axis stocks NDC00364-2433-01, NDC00591-5714-01 - Amoxapine Tablets U made by Henry Schein Inc, Watson Pharmaceuticals Inc with 6505-01-111-3195. Owned and operated by ASAP Semiconductor, we have access to over 2 billion new and after-market parts applicable within the aerospace and defense industries. All our parts are shipped using our premier shipping and supply chain. We offer short lead-times and some of the fastest shipping times in the industry. We are well-equipped to handle any customer situation - including AOG. Submit an RFQ today and expect a response within 15 minutes or less. ASAP - the evolution of purchasing.

Alternative NSN: 6505-01-111-3195
Item Name: Amoxapine Tablets U
NIIN: 011113195
NCB Code: USA (01)
Manufacturers: Henry Schein Inc, Watson Pharmaceuticals Inc
Part No Manufacturer Item Name QTY RFQ
NDC00364-2433-01 henry schein inc amoxapine tablets u Avl RFQ
NDC00591-5714-01 watson pharmaceuticals inc amoxapine tablets u Avl RFQ

Technical Characteristics of NSN 6505011113195

MRCCriteriaCharacteristic
AKJAACTIVE MEDICAMENT MEDICINAL STRENGTH50.000 MILLIGRAMS AMOXAPINE ACTIVE INGREDIENT
CQCTPRIMARY CONTAINER TYPEBOTTLE
CRLKPRIMARY CONTAINER CONTENT QUANTITY100.000 TABLETS
CXCYPART NAME ASSIGNED BY CONTROLLING AGENCYAMOXAPINE TABLETS 50MG 100S BT

Related NSN List for 6505-01-111-3195, 6505011113195

Send Instant RFQ

Low Price

Warrantied inventory at competitive prices

Find it fast

Search the world's largest inventory of electronic components by manufacturer, category or part number

Get it fast

All inventory ready to ship from our sellers

Quality guaranteed

We sell only warrantied and traceable parts

  Semiconductor's Certifications and Memberships

Thanks for Visiting Us today!

Remember, You Can Get A Competitive Quote for Your Parts Within Fifteen Minutes Or Less, Simply by Filling Out the Instant RFQ form On the Homepage.

Request for Quote

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.